Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-221547
Filing Date
2022-08-16
Accepted
2022-08-15 21:33:58
Documents
13

Document Format Files

Seq Description Document Type Size
1 425 d397498d425.htm 425 28159
2 GRAPHIC g397498425p10g1.jpg GRAPHIC 361349
3 GRAPHIC g397498425p11g1.jpg GRAPHIC 175545
4 GRAPHIC g397498425p12g1.jpg GRAPHIC 386077
5 GRAPHIC g397498425p13g1.jpg GRAPHIC 443769
6 GRAPHIC g397498425p2g1.jpg GRAPHIC 225309
7 GRAPHIC g397498425p3g1.jpg GRAPHIC 648999
8 GRAPHIC g397498425p4g1.jpg GRAPHIC 577095
9 GRAPHIC g397498425p5g1.jpg GRAPHIC 182903
10 GRAPHIC g397498425p6g1.jpg GRAPHIC 321375
11 GRAPHIC g397498425p7g1.jpg GRAPHIC 269778
12 GRAPHIC g397498425p8g1.jpg GRAPHIC 166736
13 GRAPHIC g397498425p9g1.jpg GRAPHIC 350579
  Complete submission text file 0001193125-22-221547.txt   5691521
Mailing Address 5959 HORTON STREET, SUITE 700 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 700 EMERYVILLE CA 94608 (415) 801-8073
Zymergen Inc. (Subject) CIK: 0001645842 (see all company filings)

EIN.: 462942439 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40354 | Film No.: 221168291
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filed by) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)